Takeda Pharmaceutical Co Ltd (TAK)
13.33
+0.04
(+0.30%)
USD |
NYSE |
Nov 21, 16:00
13.35
+0.02
(+0.15%)
Pre-Market: 20:00
Takeda Pharmaceutical Max Drawdown (5Y): 54.24% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 54.24% |
| September 30, 2024 | 54.24% |
| August 31, 2024 | 54.24% |
| July 31, 2024 | 54.24% |
| June 30, 2024 | 54.24% |
| May 31, 2024 | 54.24% |
| April 30, 2024 | 54.24% |
| March 31, 2024 | 54.24% |
| February 29, 2024 | 54.24% |
| January 31, 2024 | 54.24% |
| December 31, 2023 | 54.24% |
| November 30, 2023 | 54.24% |
| October 31, 2023 | 54.24% |
| September 30, 2023 | 54.24% |
| August 31, 2023 | 54.24% |
| July 31, 2023 | 54.24% |
| June 30, 2023 | 54.24% |
| May 31, 2023 | 54.24% |
| April 30, 2023 | 54.24% |
| March 31, 2023 | 54.24% |
| February 28, 2023 | 54.24% |
| January 31, 2023 | 54.24% |
| December 31, 2022 | 54.24% |
| November 30, 2022 | 54.24% |
| October 31, 2022 | 54.24% |
| Date | Value |
|---|---|
| September 30, 2022 | 54.24% |
| August 31, 2022 | 54.24% |
| July 31, 2022 | 54.24% |
| June 30, 2022 | 54.24% |
| May 31, 2022 | 54.24% |
| April 30, 2022 | 54.24% |
| March 31, 2022 | 54.24% |
| February 28, 2022 | 54.24% |
| January 31, 2022 | 54.24% |
| December 31, 2021 | 54.24% |
| November 30, 2021 | 54.24% |
| October 31, 2021 | 54.24% |
| September 30, 2021 | 54.24% |
| August 31, 2021 | 54.24% |
| July 31, 2021 | 54.24% |
| June 30, 2021 | 54.24% |
| May 31, 2021 | 54.24% |
| April 30, 2021 | 54.24% |
| March 31, 2021 | 54.24% |
| February 28, 2021 | 54.24% |
| January 31, 2021 | 54.24% |
| December 31, 2020 | 54.24% |
| November 30, 2020 | 54.24% |
| October 31, 2020 | 54.24% |
| September 30, 2020 | 54.24% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
47.36%
Minimum
Nov 2019
54.24%
Maximum
Mar 2020
53.78%
Average
54.24%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| HUTCHMED (China) Ltd | 82.18% |
| Astellas Pharma Inc | 44.10% |
| Nxera Pharma Co Ltd | 95.29% |
| PeptiDream Inc | 87.73% |
| Healios KK | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -10.17 |
| Beta (5Y) | 0.5265 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 23.74% |
| Historical Sharpe Ratio (5Y) | -0.1423 |
| Historical Sortino (5Y) | -0.2176 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.19% |